Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and preliminary efficacy of four doses of SGX201 in subjects with rectal cancer treated with concurrent radiation and chemotherapy.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01073384
Study type Interventional
Source Soligenix
Contact
Status Completed
Phase Phase 1/Phase 2
Start date December 2009
Completion date November 2012

See also
  Status Clinical Trial Phase
Completed NCT00816842 - Plasma Citrulline Concentration in Tropical Enteropathy N/A
Completed NCT00267475 - Data Bank for Eosinophilic Disorders N/A
Terminated NCT00444093 - Prospective Randomized Open Label Study of the Treatment of Therapy-associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium - Phase 3
Not yet recruiting NCT04885751 - Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy Phase 4
Completed NCT02639416 - Hypoallergenic and Anti-inflammatory Feeds in Malawian Children With Severe Acute Malnutrition (SAM) N/A
Recruiting NCT01065324 - Balloon-assisted Enteroscopy and Bacteria N/A
Completed NCT00463190 - Effect of Probiotics (Bio-Three) in Children's Enterocolitis Phase 4
Recruiting NCT03444675 - The Endoscopic Assesment of Intestinal Grafts